Van Den Berg Management I Cut Its Emerson Elec Co (EMR) Position; Thermo Fisher Scientific Inc. (TMO) Had 18 Bulls

February 20, 2018 - By Dolores Ford

Van Den Berg Management I Inc decreased Emerson Elec Co (EMR) stake by 4.05% reported in 2017Q3 SEC filing. Van Den Berg Management I Inc sold 8,460 shares as Emerson Elec Co (EMR)’s stock declined 4.02%. The Van Den Berg Management I Inc holds 200,648 shares with $12.61M value, down from 209,108 last quarter. Emerson Elec Co now has $45.78 billion valuation. The stock decreased 1.20% or $0.88 during the last trading session, reaching $72.11. About 1.27 million shares traded. Emerson Electric Co. (NYSE:EMR) has risen 18.47% since February 20, 2017 and is uptrending. It has outperformed by 1.77% the S&P500.

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 61 analyst reports since July 24, 2015 according to SRatingsIntel. As per Thursday, July 23, the company rating was maintained by Mizuho. The firm earned “Buy” rating on Tuesday, September 26 by Goldman Sachs. Leerink Swann maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Friday, April 28. Leerink Swann has “Buy” rating and $187 target. Deutsche Bank maintained the shares of TMO in report on Thursday, October 26 with “Buy” rating. On Monday, December 4 the stock rating was maintained by Leerink Swann with “Buy”. The firm has “Buy” rating given on Monday, January 11 by Stifel Nicolaus. On Friday, September 8 the stock rating was maintained by Cowen & Co with “Buy”. The company was maintained on Wednesday, October 11 by Cowen & Co. Cowen & Co maintained Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, January 31 with “Buy” rating. Cowen & Co maintained the stock with “Buy” rating in Wednesday, October 25 report. See Thermo Fisher Scientific Inc. (NYSE:TMO) latest ratings:

01/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $235 New Target: $250 Maintain
01/02/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $223 New Target: $227 Maintain
01/02/2018 Broker: Leerink Swann Rating: Buy New Target: $239.0 Maintain
01/02/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $225 New Target: $245 Maintain
01/02/2018 Broker: Jefferies Rating: Hold New Target: $230.0 Maintain
31/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $236.0 Maintain
31/01/2018 Broker: Cowen & Co Rating: Buy New Target: $220.0 Maintain
18/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $222.0 Maintain
05/01/2018 Broker: BTIG Research Rating: Buy New Target: $230 Initiates Coverage On
03/01/2018 Broker: Evercore Rating: Buy New Target: $220.0 Initiate

Investors sentiment decreased to 0.86 in 2017 Q3. Its down 0.14, from 1 in 2017Q2. It fall, as 44 investors sold EMR shares while 444 reduced holdings. 92 funds opened positions while 328 raised stakes. 432.93 million shares or 1.76% less from 440.67 million shares in 2017Q2 were reported. Livforsakringsbolaget Skandia Omsesidigt holds 12,219 shares or 0.07% of its portfolio. Apriem holds 3,329 shares or 0.05% of its portfolio. 24,641 were reported by Amica Pension Fund Board Of Trustees. Welch Ltd Llc owns 2.96% invested in Emerson Electric Co. (NYSE:EMR) for 281,596 shares. Zevin Asset Ltd Liability Com accumulated 1.65% or 111,690 shares. First Allied Advisory holds 95,724 shares or 0.26% of its portfolio. Sumitomo Mitsui Trust Hldgs invested in 0.16% or 1.83 million shares. Vaughan Nelson Mgmt Ltd Partnership accumulated 0.02% or 21,000 shares. Regions Corporation stated it has 183,913 shares. Vantage Invest Limited Liability Corporation holds 0.12% in Emerson Electric Co. (NYSE:EMR) or 7,657 shares. Front Barnett Associates Limited Liability Corporation has invested 0.05% in Emerson Electric Co. (NYSE:EMR). Delta Asset Mngmt Limited Liability Company Tn holds 1.01% of its portfolio in Emerson Electric Co. (NYSE:EMR) for 106,607 shares. Wilkins Invest Counsel stated it has 2.19% of its portfolio in Emerson Electric Co. (NYSE:EMR). Prentiss Smith And accumulated 15,102 shares or 0.57% of the stock. Murphy Pohlad Asset Mgmt Lc invested in 1.06% or 24,275 shares.

Since August 31, 2017, it had 0 insider buys, and 2 insider sales for $616,887 activity. 7,518 shares valued at $498,900 were sold by Button Bell Katherine on Monday, December 11. Another trade for 2,000 shares valued at $117,987 was made by Sharp Robert T on Thursday, August 31.

Van Den Berg Management I Inc increased Atkore Intl Group Inc stake by 745,160 shares to 1.37M valued at $26.79 million in 2017Q3. It also upped Phi Inc (NASDAQ:PHIIK) stake by 136,269 shares and now owns 1.03 million shares. Discovery Communicatns New (NASDAQ:DISCK) was raised too.

Among 29 analysts covering Emerson Electric Co. (NYSE:EMR), 12 have Buy rating, 2 Sell and 15 Hold. Therefore 41% are positive. Emerson Electric Co. had 86 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, November 7 by Cowen & Co. The firm earned “Equal-Weight” rating on Monday, October 5 by Barclays Capital. On Wednesday, January 3 the stock rating was maintained by RBC Capital Markets with “Hold”. The stock of Emerson Electric Co. (NYSE:EMR) has “Outperform” rating given on Tuesday, November 28 by Cowen & Co. The firm has “Hold” rating by Cowen & Co given on Wednesday, April 26. The firm has “Neutral” rating by Sterne Agee CRT given on Wednesday, September 9. The stock of Emerson Electric Co. (NYSE:EMR) earned “Hold” rating by RBC Capital Markets on Wednesday, April 12. The stock has “Mkt Outperform” rating by JMP Securities on Monday, June 19. The firm has “Outperform” rating given on Wednesday, February 14 by RBC Capital Markets. The firm has “Hold” rating by Societe Generale given on Thursday, November 5.

The stock decreased 0.37% or $0.77 during the last trading session, reaching $209.84. About 463,718 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since February 20, 2017 and is uptrending. It has underperformed by 1.13% the S&P500.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. The company has market cap of $84.15 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. It has a 37.53 P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: